Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$2.3 - $6.29 $356,695 - $975,484
-155,085 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$4.63 - $9.94 $280,388 - $601,956
-60,559 Reduced 28.08%
155,085 $887,000
Q4 2021

Feb 11, 2022

BUY
$8.35 - $12.6 $1.8 Million - $2.72 Million
215,644 New
215,644 $1.97 Million
Q1 2020

May 14, 2020

SELL
$10.23 - $24.56 $940,628 - $2.26 Million
-91,948 Closed
0 $0
Q4 2019

Feb 13, 2020

SELL
$17.42 - $26.61 $788,429 - $1.2 Million
-45,260 Reduced 32.99%
91,948 $2.16 Million
Q3 2019

Nov 13, 2019

SELL
$16.36 - $21.39 $502,988 - $657,635
-30,745 Reduced 18.31%
137,208 $2.58 Million
Q2 2019

Aug 08, 2019

SELL
$16.93 - $26.22 $16.1 Million - $24.9 Million
-950,032 Reduced 84.98%
167,953 $3.12 Million
Q1 2019

May 13, 2019

BUY
$23.15 - $28.34 $1.2 Million - $1.47 Million
51,722 Added 4.85%
1,117,985 $27.3 Million
Q4 2018

Feb 14, 2019

SELL
$22.03 - $32.01 $18.1 Million - $26.3 Million
-821,128 Reduced 43.51%
1,066,263 $27.5 Million
Q3 2018

Nov 13, 2018

BUY
$30.0 - $40.85 $51.7 Million - $70.3 Million
1,721,947 Added 1040.8%
1,887,391 $59.7 Million
Q2 2018

Aug 13, 2018

BUY
$26.4 - $42.0 $1.52 Million - $2.42 Million
57,518 Added 53.29%
165,444 $6.43 Million
Q1 2018

May 14, 2018

SELL
$18.43 - $28.8 $30,685 - $47,952
-1,665 Reduced 1.52%
107,926 $2.98 Million
Q4 2017

Feb 13, 2018

SELL
$14.8 - $18.85 $1,731 - $2,205
-117 Reduced 0.11%
109,591 $1.98 Million
Q3 2017

Nov 13, 2017

BUY
$14.65 - $16.85 $747 - $859
51 Added 0.05%
109,708 $1.77 Million
Q2 2017

Aug 14, 2017

BUY
N/A
16,429 Added 17.62%
109,657 $1.52 Million
Q1 2017

Apr 17, 2019

SELL
N/A
-300 Reduced 0.32%
93,228 $1.41 Million
Q4 2016

Apr 17, 2019

SELL
N/A
-74,441 Reduced 44.32%
93,528 $1.23 Million
Q3 2016

Apr 17, 2019

BUY
N/A
167,969
167,969 $2.88 Million

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $416M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.